Coldstream Capital Management Inc Acadia Pharmaceuticals Inc Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,417 shares of ACAD stock, worth $21,453. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,417Holding current value
$21,453% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ACAD
# of Institutions
348Shares Held
168MCall Options Held
267KPut Options Held
241K-
Baker Bros. Advisors LP New York, NY42.9MShares$649 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.2MShares$230 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$183 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$132 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$110 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.45B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...